These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37099321)

  • 1. The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa.
    Naik HB
    JAMA Dermatol; 2023 Jun; 159(6):581-583. PubMed ID: 37099321
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology.
    Magalhães RF; Rivitti-Machado MC; Duarte GV; Souto R; Nunes DH; Chaves M; Hirata SH; Ramos AMC
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):7-19. PubMed ID: 31166401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
    Otten M; Augustin M; Blome C; Topp J; Niklaus M; Hilbring C; Bechara FG; Pinter A; Zouboulis CC; Anzengruber F; Kirsten N
    Acta Derm Venereol; 2023 Jan; 103():adv00859. PubMed ID: 36129249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a clinical Scandinavian registry for hidradenitis suppurativa; HISREG.
    Ingvarsson G; Dufour DN; Killasli H; Sartorius K; Lapins J; Skau PA; Moseng D; Dinparvar D; Furberg AS; Jemec GB; Emtestam L
    Acta Derm Venereol; 2013 May; 93(3):350-1. PubMed ID: 23093212
    [No Abstract]   [Full Text] [Related]  

  • 6. Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4.
    van der Zee HH; van Huijstee JC; van Straalen KR; Jemec GBE; Zouboulis CC; Tzellos T; Prens EP
    Dermatology; 2024; 240(3):514-516. PubMed ID: 38118429
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical therapy is the optimal treatment for hidradenitis suppurativa.
    Daveluy S
    J Am Acad Dermatol; 2020 Sep; 83(3):977-978. PubMed ID: 32171810
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgery is an essential aspect of managing patients with hidradenitis suppurativa.
    Melendez Gonzalez MDM; Sayed CJ
    J Am Acad Dermatol; 2020 Sep; 83(3):979-980. PubMed ID: 32171813
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: A post hoc analysis of PIONEER 1 and 2 individual patient data.
    Frew JW; Jiang CS; Singh N; Grand D; Navrazhina K; Vaughan R; Krueger JG
    J Am Acad Dermatol; 2020 May; 82(5):1150-1157. PubMed ID: 31881294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations to Optimize Patient Care in Hidradenitis Suppurativa Clinics: Our Experience.
    Boothby-Shoemaker W; Rehman R; Hamzavi I; Huggins RH; Mohammad TF
    Dermatology; 2022; 238(6):1104-1107. PubMed ID: 35691279
    [No Abstract]   [Full Text] [Related]  

  • 11. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group.
    Horváth B; Janse IC; Blok JL; Driessen RJ; Boer J; Mekkes JR; Prens EP; van der Zee HH
    Acta Derm Venereol; 2017 Mar; 97(3):412-413. PubMed ID: 27535129
    [No Abstract]   [Full Text] [Related]  

  • 12. A visit guide for hidradenitis suppurativa-Managing a complex disease in a busy clinic.
    Flood KS; Porter ML; Kimball AB
    J Am Acad Dermatol; 2021 Mar; 84(3):e155-e160. PubMed ID: 33010310
    [No Abstract]   [Full Text] [Related]  

  • 13. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.
    Alikhan A; Sayed C; Alavi A; Alhusayen R; Brassard A; Burkhart C; Crowell K; Eisen DB; Gottlieb AB; Hamzavi I; Hazen PG; Jaleel T; Kimball AB; Kirby J; Lowes MA; Micheletti R; Miller A; Naik HB; Orgill D; Poulin Y
    J Am Acad Dermatol; 2019 Jul; 81(1):76-90. PubMed ID: 30872156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of mild hidradenitis suppurativa: our greatest challenge yet.
    van der Zee HH; van de Bunte M; van Straalen KR
    Br J Dermatol; 2022 Feb; 186(2):355-356. PubMed ID: 34608630
    [No Abstract]   [Full Text] [Related]  

  • 15. A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma.
    Verdelli A; Antiga E; Bonciani D; Bonciolini V; Volpi W; Caproni M
    Int J Dermatol; 2016 Jan; 55(1):e52-3. PubMed ID: 26475746
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactive, Proof of Concept Clinical Trial Design in Hidradenitis Suppurativa.
    Gottlieb AB
    J Invest Dermatol; 2021 Feb; 141(2):431-433. PubMed ID: 32585209
    [No Abstract]   [Full Text] [Related]  

  • 17. Results from the Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS).
    Br J Dermatol; 2024 Feb; 190(3):e33. PubMed ID: 38366828
    [No Abstract]   [Full Text] [Related]  

  • 18. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.